Status:
COMPLETED
Interest of the Use of Pulmonary Ultrasound in the Referral of Patients With or Suspected COVID-19 +
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Conditions:
2019-nCoV (COVID-19)
Interstitial Pneumonia
Eligibility:
All Genders
18+ years
Brief Summary
The recent pandemic due to the SARS-CoV2 results in a pulmonary infection in major symptomatic patients. Because of the large number of patients and the risk of acute respiratory distress syndrome (wh...
Detailed Description
The practitioners involved at each site are * either emergency physicians who are experts in pulmonary ultrasound * either newly trained doctors who have received 30 minutes quick training in the fun...
Eligibility Criteria
Inclusion
- Inclusion criteria :
- \> 18 years old
- Suspected of COVID-19 infection or having a systematic COVID-19 screening
- Exclusion criteria :
- Patients on whom the ultrasonographic examination is not feasible for technical reasons (morbid obesity, thoracic extensive subcutaneous emphysema, absorbent subcutaneous infiltrations, ...)
- Patients with comorbidities justifying priority intensive care, not linked to the COVID-19 condition
Exclusion
Key Trial Info
Start Date :
April 2 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 26 2020
Estimated Enrollment :
328 Patients enrolled
Trial Details
Trial ID
NCT04335019
Start Date
April 2 2020
End Date
May 26 2020
Last Update
December 1 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Urgences - Hôpital Cochin APHP
Paris, France, 75014